|
What the Science Says
Ginkgo inhibits the action of platelets in the blood, thus interfering with blood
coagulation. Don't use ginkgo if you are taking the blood thinner warfarin (Coumadin) or
antiplatelet drugs such as clopidogrel (Plavix®). Ginkgo may lower blood sugar, so
don't use it if you are already taking drugs for diabetes.
Numerous studies of ginkgo have been done for a variety of conditions. Some promising
results have been seen for intermittent claudication, but larger, well-designed research
studies are needed.
An NCCAM-funded study of the well-characterized ginkgo product, EGb-761, found it
ineffective in lowering the overall incidence of dementia and Alzheimer's disease in the
elderly. In this clinical trial, known as the Ginkgo Evaluation of Memory study,
researchers recruited more than 3,000 volunteers age 75 and over who took 240 mg of ginkgo
daily. Participants were followed for an average of approximately 6 years.
Some smaller studies for memory enhancement have had promising results, but a trial
sponsored by the National Institute on Aging of more than 200 healthy adults over age 60
found that ginkgo taken for 6 weeks did not improve memory.
Other NCCAM-funded research includes studies on ginkgo for asthma, symptoms of multiple
sclerosis, vascular function (intermittent claudication), cognitive decline, sexual
dysfunction due to antidepressants, and insulin resistance. NCCAM is also looking at
potential interactions between ginkgo and prescription drugs.
|